Continuous improvement of bone mineral density two years post zoledronic acid discontinuation in patients with thalassemia-induced osteoporosis: long-term follow-up of a randomized, placebo-controlled trial
Voskaridou, E., Christoulas, D., Konstantinidou, M., Tsiftsakis, E., Alexakos, P., Terpos, E.Volume:
93
Language:
english
Journal:
Haematologica
DOI:
10.3324/haematol.12849
Date:
October, 2008
File:
PDF, 239 KB
english, 2008